• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Infect Dis . Kinetic changes in virology, specific antibody response and imaging during the clinical course of COVID-19: a descriptive study

tetano

Editor, Senior Moderator
BMC Infect Dis


. 2020 Nov 10;20(1):818.
doi: 10.1186/s12879-020-05549-8.
Kinetic changes in virology, specific antibody response and imaging during the clinical course of COVID-19: a descriptive study


Qiu-Jing Wang[SUP] 1 [/SUP], Yan-Zhen Yao[SUP] 2 [/SUP], Jun-Shuai Song[SUP] 3 [/SUP], Qiao Wang[SUP] 4 [/SUP], Li-Yun Xu[SUP] 5 [/SUP], Zhou-Jun Bao[SUP] 2 [/SUP], Dai-Wen Mao[SUP] 1 [/SUP], Ji-Hang Zhou[SUP] 5 [/SUP], Zhe-En Zhang[SUP] 1 [/SUP], Yan Wang[SUP] 1 [/SUP], Yi-Wei Li[SUP] 2 [/SUP], He-Ping Wang[SUP] 6 [/SUP], Lue Li[SUP] 7 [/SUP], Hai-Yan Pan[SUP] 8 [/SUP], Guo-Qiang Zhang[SUP] 9 [/SUP], Shi-Bo Li[SUP] 10 [/SUP]



Affiliations

Abstract

Background: To explore the kinetic changes in virology, specific antibody response and imaging during the clinical course of COVID-19.
Methods: This observational study enrolled 20 patients with COVID-19, who were hospitalized between January 20-April 6, 2020, in the two COVID-19 designated hospitals of Zhoushan, Zhejiang and Rushan, Shandong, China, The laboratory findings, imaging, serum response to viral infection, and viral RNA level in the throat and stool samples were assessed from onset to recovery phase in patients with COVID-19.
Results: SARS-COV-2 RNA was positive as early as day four. It remained positive until day 55 post-onset in the sputum-throat swabs and became negative in most cases (55%) within 14 days after onset. Lymphocytopenia occurred in 40% (8/20) of patients during the peak infection period and returned to normal at week five. The most severe inflammation in the lungs appeared in week 2 or 3 after onset, and this was completely absorbed between week 6 and 8 in 85.7% of patients. All patients had detectable antibodies to the receptor binding domain (RBD), and 95% of these patients had IgG to viral N proteins. The antibody titer peaked at week four. Anti-S IgM was positive in 7 of 20 patients after week three.
Conclusions: All COVID-19 patients in this study were self-limiting and recovered well though it may take as long as 6-8 weeks. Our findings on the kinetic changes in imaging, serum response to viral infection and viral RNA level may help understand pathogenesis and define clinical course of COVID-19.

Keywords: Antibody response and qRT-PCR; COVID-19; Lung image; SARS-CoV-2.
 
Back
Top Bottom